Medline ® Abstract for Reference 65
of 'The ketogenic diet and other dietary therapies for the treatment of epilepsy'
65
TI
Use of a modified Atkins diet in intractable childhood epilepsy.
AU
Kang HC, Lee HS, You SJ, Kang du C, Ko TS, Kim HD
SO
Epilepsia. 2007;48(1):182.
PURPOSE:
To evaluate the efficacy, safety and tolerability of a modified Atkins diet in intractable childhood epilepsy.
METHODS:
Fourteen children with epilepsy were treated prospectively with a modified Atkins diet. Outcome measures included seizure frequency, adverse reactions and tolerability to the diet; blood beta-hydroxybutyrate and urine ketones were also measured.
RESULTS:
Six months after diet initiation, seven (50%) remained on the diet, five (36%) had>50% seizure reduction, and three (21%) were seizure free. The diet was well tolerated by 12 (86%) patients. Most complications were transient and were successfully managed by careful follow-up and conservative strategies. A consistently strong ketosis (beta-hydroxybutyrate of>3 mmol/L) seemed to be important for maintaining the efficacy of the diet therapy.
CONCLUSIONS:
The modified Atkins diet was well tolerated and sometimes a modified Atkins diet can be substituted for the conventional ketogenic diet. Serious complications were rare, but long-term complications remain to be determined.
AD
Department of Pediatrics, Epilepsy Center, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
PMID